Evidence map›Paper›PMID 26491060›Full record

ArticleHealth policy and planning2016

Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis.

Kirsten Bjerkreim Strand, Dan Chisholm, Abebaw Fekadu, Kjell Arne Johansson

Open access · hybridAbstract read
In one paragraph

Article in Health policy and planning, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 5 pooled it
12.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 5 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.Medical decision making : an international journal of the Society for Medical Decision Making · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Global Health and Epilepsy: Update and Future Directions.Current neurology and neuroscience reports · 2019
    Review
  16. Review
  17. Review
  18. Moving towards universal health coverage for mental disorders in Ethiopia.International journal of mental health systems · 2019
    Article
  19. Article
  20. Systematic review of pharmacoeconomic models for schizophrenia.Journal of market access & health policy · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Kirsten Bjerkreim StrandDepartment of Global Public Health and Primary Care University of Bergen Postbox 7804, N- 5020 Bergen, kirstenbjp@gmail.com.
Dan ChisholmWorld Health Organization, Geneva, Switzerland.
Abebaw FekaduCollege of Health Sciences, School of Medicine, Department of Psychiatry, University of Addis Abeba, Addis Ababa, Ethiopia and Institute of Psychiatry, Department of Psychological Medicine, King's College London, London, UK.
Kjell Arne JohanssonDepartment of Global Public Health and Primary Care University of Bergen Postbox 7804, N- 5020 Bergen.
University of Bergen · NOAddis Ababa University · ETWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionThere is an immense need for scaling-up neuropsychiatric care in low-income countries. Contextualized cost-effectiveness analyses (CEAs) provide relevant information for local policies. The aim of this study is to perform a contextualized CEA of neuropsychiatric interventions in Ethiopia and to illustrate expected population health and budget impacts across neuropsychiatric disorders.

methodsA mathematical population model (PopMod) was used to estimate intervention costs and effectiveness. Existing variables from a previous WHO-CHOICE regional CEA model were substantially revised. Treatments for depression, schizophrenia, bipolar disorder and epilepsy were analysed. The best available local data on epidemiology, intervention efficacy, current and target coverage, resource prices and salaries were used. Data were obtained from expert opinion, local hospital information systems, the Ministry of Health and literature reviews.

resultsTreatment of epilepsy with a first generation antiepileptic drug is the most cost-effective treatment (US$ 321 per DALY adverted). Treatments for depression have mid-range values compared with other interventions (US$ 457-1026 per DALY adverted). Treatments for schizophrenia and bipolar disorders are least cost-effective (US$ 1168-3739 per DALY adverted).

conclusionThis analysis gives the Ethiopian government a comprehensive overview of the expected costs, effectiveness and cost-effectiveness of introducing basic neuropsychiatric interventions.

Indexed as

AnticonvulsantsBipolar DisorderCapacity BuildingCost-Benefit AnalysisDepressionEpilepsyEthiopiaHealth Care CostsHumansMental Health ServicesSchizophreniaAnticonvulsantsCost-effectivenessethicsmental healthneuropsychiatric disorders

Identifiers

PMID26491060
PMCPMC4986243
OpenAlexW2174115892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.